116 related articles for article (PubMed ID: 35139425)
1. Shed syndecan-2 enhances colon cancer progression by increasing cooperative angiogenesis in the tumor microenvironment.
Jang B; Song HK; Hwang J; Lee S; Park E; Oh A; Hwang ES; Sung JY; Kim YN; Park K; Lee YM; Oh ES
Matrix Biol; 2022 Mar; 107():40-58. PubMed ID: 35139425
[TBL] [Abstract][Full Text] [Related]
2. Shed syndecan-2 enhances tumorigenic activities of colon cancer cells.
Choi S; Choi Y; Jun E; Kim IS; Kim SE; Jung SA; Oh ES
Oncotarget; 2015 Feb; 6(6):3874-86. PubMed ID: 25686828
[TBL] [Abstract][Full Text] [Related]
3. Shed syndecan-2 inhibits angiogenesis.
De Rossi G; Evans AR; Kay E; Woodfin A; McKay TR; Nourshargh S; Whiteford JR
J Cell Sci; 2014 Nov; 127(Pt 21):4788-99. PubMed ID: 25179601
[TBL] [Abstract][Full Text] [Related]
4. Syndecan-2 functions as a docking receptor for pro-matrix metalloproteinase-7 in human colon cancer cells.
Ryu HY; Lee J; Yang S; Park H; Choi S; Jung KC; Lee ST; Seong JK; Han IO; Oh ES
J Biol Chem; 2009 Dec; 284(51):35692-701. PubMed ID: 19858218
[TBL] [Abstract][Full Text] [Related]
5. Syndecan-2 cytoplasmic domain regulates colon cancer cell migration via interaction with syntenin-1.
Lee H; Kim Y; Choi Y; Choi S; Hong E; Oh ES
Biochem Biophys Res Commun; 2011 May; 409(1):148-53. PubMed ID: 21569759
[TBL] [Abstract][Full Text] [Related]
6. Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis.
Purushothaman A; Uyama T; Kobayashi F; Yamada S; Sugahara K; Rapraeger AC; Sanderson RD
Blood; 2010 Mar; 115(12):2449-57. PubMed ID: 20097882
[TBL] [Abstract][Full Text] [Related]
7. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer.
Shinagawa K; Kitadai Y; Tanaka M; Sumida T; Onoyama M; Ohnishi M; Ohara E; Higashi Y; Tanaka S; Yasui W; Chayama K
Int J Cancer; 2013 Feb; 132(4):813-23. PubMed ID: 22821812
[TBL] [Abstract][Full Text] [Related]
8. PPARδ deficiency disrupts hypoxia-mediated tumorigenic potential of colon cancer cells.
Jeong E; Koo JE; Yeon SH; Kwak MK; Hwang DH; Lee JY
Mol Carcinog; 2014 Nov; 53(11):926-37. PubMed ID: 24610641
[TBL] [Abstract][Full Text] [Related]
9. The extracellular domain of syndecan-2 regulates the interaction of HCT116 human colon carcinoma cells with fibronectin.
Kwon MJ; Kim Y; Choi Y; Kim SH; Park S; Han I; Kang DH; Oh ES
Biochem Biophys Res Commun; 2013 Feb; 431(3):415-20. PubMed ID: 23333331
[TBL] [Abstract][Full Text] [Related]
10. KLK10 derived from tumor endothelial cells accelerates colon cancer cell proliferation and hematogenous liver metastasis formation.
Kato K; Noda T; Kobayashi S; Sasaki K; Iwagami Y; Yamada D; Tomimaru Y; Takahashi H; Uemura M; Asaoka T; Shimizu J; Doki Y; Eguchi H
Cancer Sci; 2024 May; 115(5):1520-1535. PubMed ID: 38475666
[TBL] [Abstract][Full Text] [Related]
11. Syndecan-1 is required for robust growth, vascularization, and metastasis of myeloma tumors in vivo.
Khotskaya YB; Dai Y; Ritchie JP; MacLeod V; Yang Y; Zinn K; Sanderson RD
J Biol Chem; 2009 Sep; 284(38):26085-95. PubMed ID: 19596856
[TBL] [Abstract][Full Text] [Related]
12. The matrix metalloproteinase-7 regulates the extracellular shedding of syndecan-2 from colon cancer cells.
Choi S; Kim JY; Park JH; Lee ST; Han IO; Oh ES
Biochem Biophys Res Commun; 2012 Jan; 417(4):1260-4. PubMed ID: 22227189
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory hypoxia induces syndecan-2 expression through IL-1β-mediated FOXO3a activation in colonic epithelia.
Choi S; Chung H; Hong H; Kim SY; Kim SE; Seoh JY; Moon CM; Yang EG; Oh ES
FASEB J; 2017 Apr; 31(4):1516-1530. PubMed ID: 28031321
[TBL] [Abstract][Full Text] [Related]
14. Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer.
Liu Y; Han ZP; Zhang SS; Jing YY; Bu XX; Wang CY; Sun K; Jiang GC; Zhao X; Li R; Gao L; Zhao QD; Wu MC; Wei LX
J Biol Chem; 2011 Jul; 286(28):25007-15. PubMed ID: 21592963
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-1 overexpression promotes tumor growth and angiogenesis in an endometrial cancer xenograft model.
Oh JH; Lee HS; Park SH; Ryu HS; Min CK
Int J Gynecol Cancer; 2010 Jul; 20(5):751-6. PubMed ID: 20973264
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived, alternatively activated macrophages enhance solid tumor growth and lung metastasis of mammary carcinoma cells in a Balb/C mouse orthotopic model.
Cho HJ; Jung JI; Lim DY; Kwon GT; Her S; Park JH; Park JH
Breast Cancer Res; 2012 May; 14(3):R81. PubMed ID: 22616919
[TBL] [Abstract][Full Text] [Related]
17. Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts.
Miyazaki S; Kikuchi H; Iino I; Uehara T; Setoguchi T; Fujita T; Hiramatsu Y; Ohta M; Kamiya K; Kitagawa K; Kitagawa M; Baba S; Konno H
Int J Cancer; 2014 Jul; 135(2):295-307. PubMed ID: 24375080
[TBL] [Abstract][Full Text] [Related]
18. A high-fat diet increases angiogenesis, solid tumor growth, and lung metastasis of CT26 colon cancer cells in obesity-resistant BALB/c mice.
Park H; Kim M; Kwon GT; Lim DY; Yu R; Sung MK; Lee KW; Daily JW; Park JH
Mol Carcinog; 2012 Nov; 51(11):869-80. PubMed ID: 21919080
[TBL] [Abstract][Full Text] [Related]
19. Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer.
Kawada M; Seno H; Kanda K; Nakanishi Y; Akitake R; Komekado H; Kawada K; Sakai Y; Mizoguchi E; Chiba T
Oncogene; 2012 Jun; 31(26):3111-23. PubMed ID: 22056877
[TBL] [Abstract][Full Text] [Related]
20. Syndecan-2 regulates cell migration in colon cancer cells through Tiam1-mediated Rac activation.
Choi Y; Kim H; Chung H; Hwang JS; Shin JA; Han IO; Oh ES
Biochem Biophys Res Commun; 2010 Jan; 391(1):921-5. PubMed ID: 19962968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
